The goal of this clinical trial is to study the effects of an experimental (not Food and Drug Administration (FDA)-approved) treatment called corneal crosslink…

KeratoconusEctasia of CorneaPellucid Marginal Corneal Degeneration+1 more

~Estimated

~$10 – $7,500

Woolfson Eye InstituteNCT07124910

Phase 2

Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia

To evaluate the safety and effectiveness of the PXL Platinum 330 system for performing corneal cross-linking (CXL) for the treatment of ectatic disorders.

KeratoconusPellucid Marginal Corneal DegenerationCorneal Ectasia

~Estimated

~$10 – $7,500

Goodman Eye CenterNCT04094090